0.49
0.49 (0%)
As of Apr 17, 2025
Verrica Pharmaceuticals Inc. [VRCA]
Source:
Company Overview
Verrica Pharmaceuticals Inc. is a dermatology therapeutics company developing and selling medications for skin diseases requiring medical intervention. Our commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need.
| Country | United States |
| Headquarters | west chester, pennsylvania |
| Phone Number | 484-453-3300 |
| Industry | manufacturing |
| CEO | Ted White |
| Website | www.verrica.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $7.6 |
| Operating Profit | $-65.9 |
| Net Income | $-76.6 |
| Net Cash | $-23.2 |
Profit Ratios
| Gross Margin | $4.8 |
| Operating Margin | -871.3 |
| Profit as % of Revenues | -6.3% |
| Profit as % of Assets | -112.8% |
| Profit as % of Stockholder Equity | 776.7% |
Management Effectiveness
| Return on Equity | 776.7% |
| Return on Assets | -141.5% |
| Turnover Ratio | 11.2% |
| EBITA | $-65.9 |
Balance Sheet and Cash Flow Measures
| Total Assets | $54.1 |
| Total Liabilities | $64 |
| Operating Cash Flow | $-60.9 |
| Investing Cash Flow | $-0 |
| Financing Cash Flow | $37.7 |
